Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Zoledronic Acid Vs Pamidronate

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00164008Phase 4Completed

Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention

Showing all 1 trials

Research Network

Common Treatments

  • Zoledronic Acid Vs Pamidronate1

Active Sponsors

  • Bayside Health1
  • Novartis1

Top Investigators

Related Conditions

  • Other Complications Of Lung Transplant1
  • Osteopenia1

Activity Timeline